What is Mycorena?
Mycorena, operating under the brand Promyc, is at the forefront of developing sustainable and nutritious meat alternatives. The company specializes in 100% natural fermented mycoproteins, targeting B2B clients seeking to enhance their food product lines with innovative plant-based proteins. Promyc's core strength lies in its co-creation approach, collaborating with partners to craft unique food items that satisfy consumer demand for high-protein, meat-free options. Their proprietary fermentation technology leverages locally sourced ingredients to produce advanced mycoprotein structures, positioning them as a key player in the future of food.
How much funding has Mycorena raised?
Mycorena has raised a total of $26.8M across 1 funding round:
Series A
$26.8M
Series A (2022): $26.8M, investors not publicly disclosed
What's next for Mycorena?
The substantial enterprise-level funding indicates a strategic push for Mycorena to scale its operations and expand its market reach. This capital infusion is likely to fuel further research and development, enhance production capabilities, and strengthen its B2B partnerships. As the demand for sustainable protein sources continues to grow, Mycorena is well-positioned to capitalize on this trend, potentially leading to further market penetration and product innovation in the alternative food sector.
See full Mycorena company page
